CXCR4 expression is an (A) IPI score, (B) ABC/GCB subclass, (C) CD20 expression, and (D) GCB-CC/CB subtype-independent prognostic marker for R-CHOP-treated DLBCL patients. Here, CXCR4 is linked to diffuse large B-cell lymphoma.